Molina Healthcare, Inc. offers comprehensive managed health care services, primarily targeting economically disadvantaged families and individuals. The company provides coverage through key ...
This article provides a risk profile for the Molina Healthcare, Inc. 6.25% 15-JAN-2033 bond (MOH5939489 FINRA). It outlines key metrics for credit risk assessment, including security level, inflation protection, and issuer rating, to help investors evaluate the bond's reliability. The page also mentions access to exclusive analyst ratings for bonds.
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Molina Healthcare, Inc. (MOH) concerning potential corporate wrongdoing by the company and its officers/directors. The firm is encouraging investors who purchased Molina securities before February 5, 2025, and still hold them, to join the investigation. The representation is on a contingency fee basis, meaning investors incur no upfront costs.
Molina Healthcare (MOH) has experienced a technical reshuffling in Russell style indices, moving into the Russell 2500 Index and Russell 2500 Value Benchmark, following a significant Illinois HealthChoice Medicaid contract win. This index change is viewed as technical rather than fundamental, with the core investment narrative still centered on Medicaid contract performance, cost controls, and policy stability. While the Illinois contract boosts future revenue projections, the company's financial outlook remains sensitive to potential Medicaid funding shifts.
Molina Healthcare (MOH) was recently reclassified in several Russell indices after securing a significant Illinois HealthChoice Medicaid contract. This article examines how the new contract and index changes impact Molina's investment narrative and future earnings, highlighting the company's reliance on Medicaid contracts, cost control, and policy stability, while also noting potential downside risks and providing a fair value estimate.
Centene Corporation's subsidiary, Meridian Health Plan of Illinois, has secured a four-year renewal of its contract under the state's HealthChoice Illinois Medicaid program, effective from January 1, 2027, through 2030. This renewal, while not expected to significantly boost near-term earnings, is critical for maintaining premium revenues and enhancing long-term earnings visibility for Centene, given its reliance on government-sponsored healthcare programs. The company's shares have rallied 64.3% year-to-date, outperforming the industry, and its 2026 earnings are projected to grow by 66.4%.
This article provides a risk profile for the Molina Healthcare, Inc. 6.25% 15-JAN-2033 bond (MOH5939489 FINRA). It outlines key metrics for credit risk assessment, including security level, inflation protection, and issuer rating, to help investors evaluate the bond's reliability. The page also mentions access to exclusive analyst ratings for bonds.
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Molina Healthcare, Inc. (MOH) concerning potential corporate wrongdoing by the company and its officers/directors. The firm is encouraging investors who purchased Molina securities before February 5, 2025, and still hold them, to join the investigation. The representation is on a contingency fee basis, meaning investors incur no upfront costs.
Molina Healthcare (MOH) has experienced a technical reshuffling in Russell style indices, moving into the Russell 2500 Index and Russell 2500 Value Benchmark, following a significant Illinois HealthChoice Medicaid contract win. This index change is viewed as technical rather than fundamental, with the core investment narrative still centered on Medicaid contract performance, cost controls, and policy stability. While the Illinois contract boosts future revenue projections, the company's financial outlook remains sensitive to potential Medicaid funding shifts.
Molina Healthcare (MOH) was recently reclassified in several Russell indices after securing a significant Illinois HealthChoice Medicaid contract. This article examines how the new contract and index changes impact Molina's investment narrative and future earnings, highlighting the company's reliance on Medicaid contracts, cost control, and policy stability, while also noting potential downside risks and providing a fair value estimate.
Centene Corporation's subsidiary, Meridian Health Plan of Illinois, has secured a four-year renewal of its contract under the state's HealthChoice Illinois Medicaid program, effective from January 1, 2027, through 2030. This renewal, while not expected to significantly boost near-term earnings, is critical for maintaining premium revenues and enhancing long-term earnings visibility for Centene, given its reliance on government-sponsored healthcare programs. The company's shares have rallied 64.3% year-to-date, outperforming the industry, and its 2026 earnings are projected to grow by 66.4%.
Barclays has reaffirmed its Hold rating on Agilon Health (AGL), setting a price target of $81.00. Analyst Andrew Mok CFA covers the Healthcare sector and has a 51.86% success rate. The broader analyst consensus for Agilon Health is also a Hold, with an average price target of $57.15, following the company's recent earnings report of $1.42 billion in quarterly revenue and a net profit of $29.97 million.
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Molina Healthcare, Inc. (MOH) concerning potential corporate wrongdoing. The firm is encouraging investors who purchased Molina securities before February 5, 2025, and still hold them, to contact them to learn more and assist in the investigation. The firm operates on a contingency fee basis and aims to recover investor capital and ensure corporate accountability.
RBC Capital Markets has increased its price target for Molina Healthcare (MOH) shares to $248 from $216, while reiterating a Sector Perform rating on the stock. This adjustment reflects a revised outlook from the analyst firm regarding the healthcare company.
Molina Healthcare, a US-based managed care company, focuses on government-sponsored health insurance programs like Medicaid and Medicare. The company's stock performance is closely tied to enrollment growth, cost management, and US policy changes for these programs. Molina Healthcare competes for state contracts and aims to manage medical costs effectively while providing access to care for vulnerable populations.
Alignment Healthcare (ALHC) is leveraging AI and automation to improve Medicare Advantage economics, focusing on cost control through automated claims processing and back-office operations, as well as more effective management of high-acuity members. The company emphasizes quality plans and strong member retention to drive growth, despite facing challenges like the CMS V28 risk adjustment model and profitability issues with PPO plans. ALHC is positioned as a growth trend play due to its strategic use of technology and targeted care.
Molina Healthcare is a managed care company focused on providing health services to Medicaid and Medicare members across the United States. The company's core business involves Medicaid managed care contracts and Medicare Advantage plans, emphasizing value-based care and cost control. Investors track Molina Healthcare for its enrollment trends in government-sponsored programs, operational discipline, and ability to manage medical costs and adapt to regulatory changes.
Molina Healthcare (MOH) stock recently hit a new 52-week high at $237.96, reflecting a 34% year-to-date return despite a slight annual decline. The company also secured a significant Medicaid contract in Illinois starting in 2027 and received a "Sector Perform" rating from RBC Capital, with a price target of $216. InvestingPro analysis suggests the stock is currently undervalued.
Molina Healthcare Inc. (MOH) recently hit a 52-week high of $237.96, reflecting a 34% year-to-date return but a slight annual decline of 0.33%. Despite the recent surge, InvestingPro indicates the stock may be undervalued. The company also secured a significant Medicaid contract in Illinois and received a "Sector Perform" rating from RBC Capital, with a $216 price target.
Molina Healthcare Inc. (MOH) stock recently hit a 52-week high of $237.96, showing strong recent performance with a 34% year-to-date return despite a slight decline over the past year. The company secured a major Medicaid contract in Illinois starting in 2027 and RBC Capital initiated coverage with a "Sector Perform" rating, setting a $216 price target. Increased options trading also indicates heightened investor interest in MOH.
The Molina Healthy Advantage Silver 2470 is a Medicare Advantage plan from Molina Healthcare designed for beneficiaries seeking predictable copays and integrated benefits in specific US markets. This plan combines Medicare Parts A and B, typically D, focusing on coordinated care and fixed costs for primary and specialist visits. It's particularly relevant to investors in Molina Healthcare (NYSE: MOH) as it reflects the company's strategy in the government-sponsored health plan sector under CMS oversight.
Molina Healthcare Inc. (MOH) shares rose 2.28% to $232.90 on Tuesday, despite a general market downturn where the S&P 500 and Dow Jones Industrial Average both fell. This increase broke a two-day losing streak for the stock. The outperformance occurred during a poor trading session for the broader stock market.
Alignment Healthcare (ALHC) has shown improved profitability, higher guidance, and stronger cash flow, but its stock rally means its current price may already reflect much of this operational progress. While the company's fundamentals are improving, its current valuation is higher than its historical median, suggesting that further upside may depend on fresh estimate momentum or a more attractive entry point. Analysts offer a modest 1.5% average price target increase from the last closing price.
Molina Healthcare specializes in providing managed care services to Medicaid and Medicare beneficiaries across various U.S. states. The company's business model is deeply intertwined with government-sponsored health plans, making policy changes and enrollment trends critical factors for its investors. Its focus on public health coverage means its growth depends significantly on enrollment numbers and state-designed coverage contracts, requiring a balance between competitive bids and quality care delivery.
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Molina Healthcare, Inc. (MOH) for alleged corporate wrongdoing. The firm encourages investors who purchased Molina securities before February 5, 2025, and still hold them, to join the investigation. Bronstein, Gewirtz & Grossman, LLC represents investors on a contingency fee basis to recover capital and ensure corporate accountability.
Nealesh D. Shah, SVP and CFO of Kosmos Energy Ltd., sold 45,980 shares of the company's common stock for a total of $94,258 on July 2, 2026, to cover tax withholding requirements from restricted share unit vesting. This sale followed his acquisition of 118,329 shares on July 1, 2026, through vested restricted share units. Despite the sale, Shah directly holds 1,935,410 shares, and the company's stock has seen a significant surge year-to-date, although it faces profitability challenges and recent mixed analyst ratings.
Alignment Healthcare (ALHC) is attracting investor interest due to strong Medicare Advantage growth, high-quality ratings, and increasing operating leverage translating into profitability. The company reported a Q1 2026 profit and raised its full-year membership and revenue outlook, though utilization and execution risks remain. ALHC's focus on quality, retention, and automation is driving margin expansion, positioning it as a growth story with improving fundamentals despite some operational challenges.
Molina Healthcare's stock is performing well due to investor focus on the company's growth in Medicaid and Medicare memberships, disciplined margin management, and strategic capital deployment within the evolving US managed-care market. The company's business model relies on government contracts, with its success tied to efficient care management, cost control, and adaptability to regulatory changes. Investors closely monitor membership trends, operational efficiency, and capital allocation as key drivers of the company's financial performance.
This document is a transcript of Molina Healthcare's Q1 2026 earnings call, provided by Quartr. It focuses solely on the company's financial performance and discussions during the call. The content is primarily the verbatim record of the earnings presentation and Q&A.
Ambetter health plans by Centene Corp. are a major product line on the Affordable Care Act (ACA) marketplaces, providing essential health benefits to millions of US families. The plans offer tiered options (bronze, silver, gold), digital tools, and focus on affordability for individuals and families without employer-sponsored coverage. Ambetter's presence across many states and its integration with ACA subsidies make it a significant player in the national health insurance landscape, affecting both consumers and Centene's financial performance.
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Molina Healthcare, Inc. (MOH) who bought securities prior to February 5, 2025, and still hold them. The investigation focuses on whether Molina, its officers, and/or directors engaged in corporate wrongdoing. Investors are encouraged to contact the firm to assist with the investigation, which is conducted on a contingency fee basis.
This article provides financial information for Molina Healthcare Inc. (NYSE: MOH), specifically focusing on its forward price-to-earnings ratio. The content is presented within the TradingView platform and indicates that no current trades were observed at the time of access.
Molina Healthcare specializes in government-sponsored health plans, primarily focusing on Medicaid, Medicare, and Affordable Care Act (ACA) marketplaces. The company operates as a managed care organization, contracting with state agencies to provide health benefits to vulnerable populations, emphasizing care coordination and cost control. Its business model, which includes a diversified portfolio of government-related health plans, is attractive to investors interested in publicly funded healthcare.
Molina Healthcare (MOH) was recently reclassified into the Russell 2500 and Russell 2500 Value indices, moving out of growth and defensive indices. This shift reflects an emphasis on its value characteristics, though the core investment narrative remains tied to its Medicaid-centric model and managing medical costs. The reclassification and recent risk adjustment transfers highlight ongoing challenges to earnings quality, influencing its fair value and future outlook.
Molina Healthcare is a major managed care provider in the US, primarily serving individuals through government-sponsored Medicaid and Medicare Advantage programs. The company's business model relies on fixed per-member-per-month payments, making cost management and efficient medical care crucial to its financial performance. Molina Healthcare aims for long-term growth by deepening its presence in existing states and entering new markets, carefully balancing expansion with capital discipline and regulatory requirements.
This article displays the "Enterprise value to EBIT forward" for Molina Healthcare Inc. (NYSE: MOH). The content primarily consists of navigation and financial data presentation, with the specific value for the metric appearing under the "Period" and "Value" columns.
This article provides financial data for Molina Healthcare Inc (NYSE: MOH), specifically focusing on its enterprise value to revenue forward metric. The information is presented within a TradingView context, displaying details like market status, financial overview, and related data sources. The content itself seems to be a data point or a prompt for further financial analysis rather than a narrative article.
This article focuses on the "Price to sales forward" metric for Molina Healthcare Inc (NYSE: MOH). It provides a snapshot of this financial ratio sourced from TradingView, indicating specific period values and changes. The content is primarily a data presentation page from a financial platform.
This article provides financial information for Molina Healthcare, Inc. under the GETTEX:MHG ticker. It focuses specifically on the "Price to sales forward" metric, indicating a financial analysis tool provided by TradingView. The page displays the current trading status and financial details for the company.
This article provides a list of Exchange Traded Funds (ETFs) that hold Molina Healthcare, Inc. (MHG) stocks. The list is sorted by market value and includes various details such as weight, issuer, management style, expense ratio, assets under management (AUM), price, change percentage, and 3-year NAV total return. The ETFs cover different market segments like small-cap, mid-cap, large-cap, and sector-specific healthcare funds.
Molina Healthcare is focusing on its Medicaid and Medicare managed care business, which benefits from strong demand for government-sponsored health coverage in the U.S. The company's strategy emphasizes stable enrollment, disciplined cost management, and diversification through Medicare Advantage and health insurance marketplace plans. Success hinges on winning and retaining state and federal contracts, managing medical costs, and demonstrating quality outcomes.
Molina Healthcare (MOH) was recently reclassified into Russell 2500 Value indices, indicating a shift in its investor base towards value characteristics. This reclassification occurs amidst challenges such as exchange risk adjustment transfers and potential medical cost inflation, which could impact its Medicaid-focused business model. Despite these challenges, the article highlights varying analyst forecasts and encourages investors to conduct their own analysis, suggesting that the core investment narrative remains Medicaid-centric.
Molina Healthcare (MOH) was recently reclassified into Russell 2500 and Russell 2500 Value indices, moving out of growth and defensive indices. This shift highlights a focus on its value characteristics and Medicaid-centric model, despite facing headwinds from exchange risk adjustment transfers and persistent medical cost inflation. The article discusses how this reclassification and recent financial developments, including an estimated US$11.2 million additional payment for exchange risk adjustment transfers, impact Molina's investment narrative and earnings outlook, projecting a 17% downside from its current price based on fair value estimates.
Molina Healthcare director Dale B. Wolf received a quarterly equity award of 237 common shares, valued at $55,000, as part of his director compensation under the company's 2025 Equity Incentive Plan. This grant, based on the closing price of $232.55 on July 1, 2026, increased his indirect holdings to 15,633 shares held in a revocable trust. The award represents a quarter of his annual equity compensation, which totals $220,000.
Molina Healthcare director Steven J. Orlando, through the Orlando Family Trust, received a grant of 237 shares of common stock on July 1, 2026. This grant values at $55,000, part of a $220,000 annual director equity package under the company’s 2025 Equity Incentive Plan. Following this transaction, the trust holds 17,967 shares, with an additional 1,500 shares held indirectly through Orlando’s 401(k) plan.
Molina Healthcare director Richard M. Schapiro received a quarterly stock grant of 237 shares, valued at $55,000, as part of his annual $220,000 equity compensation. This grant, issued on July 1, 2026, under the company's 2025 Equity Incentive Plan, increased his direct holdings to 12,311 shares of common stock. The transaction reflects routine equity-based compensation for his board service.
Molina Healthcare director Richard C. Zoretic was granted 237 shares of common stock, valued at $55,000, as part of his board service compensation. This grant, under the company's 2025 Equity Incentive Plan, represents a quarterly portion of a $220,000 annual equity package, calculated based on the stock's closing price of $232.55 per share on July 1, 2026. After this transaction, Zoretic indirectly holds 9,389 shares through his revocable living trust.
Molina Healthcare director Ronna Romney's revocable trust received a quarterly stock grant of 237 shares, valued at $55,000. This award is part of her annual $220,000 equity compensation under the 2025 Equity Incentive Plan, based on the stock's closing price of $232.55 on July 1, 2026. Following this transaction, her trust indirectly holds 17,869 Molina Healthcare shares.
Investing.com published a report titled "Form 4 Molina Healthcare Inc For: 2 July," noting that Molina Healthcare's stock (MOH) experienced a -1.25% change. The article primarily functions as a placeholder for a financial filing and includes various market data and other news headlines.
Molina Healthcare director Leo P. Grohowski received a quarterly stock grant of 237 shares of common stock, valued at $55,000, on July 1, 2026. This grant, part of the company's 2025 Equity Incentive Plan, compensates him for his board service. Following this transaction, Grohowski directly holds 1,542 shares of Molina Healthcare common stock.
Molina Healthcare director Francis S. Soistman Jr. received a grant of 237 shares of common stock valued at $55,000 on July 1, 2026, as part of his director compensation under the company's 2025 Equity Incentive Plan. This quarterly award is based on an annual equity award of $220,000, and the shares were granted at a closing price of $232.55 per share. Following this transaction, Soistman directly holds 907 shares of Molina Healthcare common stock.
Molina Healthcare's Chief Operating Officer, James Woys, acquired 144 shares of common stock through the company's 2019 Employee Stock Purchase Plan (ESPP) at a price of $147.51 per share. This purchase represents 85% of the lower closing price during the offering period. Following this transaction, Woys directly holds 90,178 shares of Molina Healthcare common stock.
Molina Healthcare EVP Debra Bacon recently reported insider transactions, including the acquisition of 23 shares through the Employee Stock Purchase Plan (ESPP) on June 30, 2026. On July 1, 2026, she surrendered 183 shares to cover withholding taxes related to the vesting of 529 shares. Following these transactions, Bacon directly holds 21,636 Molina Healthcare shares, with additional restricted shares scheduled to vest in 2027, 2028, and 2029.
Molina Healthcare's Chief Legal Officer, Jeff D. Barlow, acquired 138 shares of company common stock on June 30, 2026, through the 2019 Employee Stock Purchase Plan at a price of $147.51 per share. This transaction increases his direct holdings to 67,313 shares. The purchase price was determined based on 85% of the lower closing price, with a reference price of $173.54.
Molina Healthcare Inc. (MOH) shares dropped by 1.15% to $229.87, on a mixed day for the broader market. Despite this daily loss, the stock closed 14.28% below its 52-week high, indicating strong performance relative to its peak. The S&P 500 remained largely unchanged, while the Dow Jones Industrial Average saw a gain.
Molina Healthcare, a US-based managed care company, specializes in providing health insurance services through government programs like Medicaid and Medicare. The company's growth and profitability are closely tied to enrollment levels, effective management of medical costs relative to fixed payments, and the ever-changing policy environment surrounding public health coverage. Investors closely monitor these factors, along with regulatory developments and industry performance, to assess Molina Healthcare's financial health and future prospects.
